Abstract
This chapter offers a summary of therapeutic modalities employed in treating diseases in nuclear medicine. Therapy in nuclear medicine is accomplished by particulate radiations (β- and α-particles) given off by radiopharmaceuticals. Hyperthyroidism and thyroid cancer are treated with 131I, and the conditions of treatment are discussed at length along with the pros and cons of the treatment. Polycythemia vera and leukemia are treated with 32P–sodium orthophosphate to destroy red blood cells and white blood cells, respectively, to bring them to normal values. 90Y-labeled TheraSpheres and Sir-Spheres are used to treat hepatocellular carcinoma, whereas 90Y-labeled ibritumomab tiuxetan is used to treat non-Hodgkin’s lymphoma. Bone pain is a common effect of metastasis of various cancers, and palliative treatment with 89Sr-strontium chloride and 153Sm-EDTMP mitigates the pain.
The use of α treatment of prostate cancer and its metastasis with 223Ra-radium chloride is highlighted.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences and Suggested Reading
Becker D, Hurley JR. Radioiodine treatment of hyperthyroidism. In: Sandler MP, Coleman RE, FJT W, et al., editors. Diagnostic nuclear medicine. 3rd ed. Baltimore: Williams and Wilkins; 1996. p. 943.
Farhanghi M, Holmes RA, Volkert WA, et al. Samarium-153-EDTMP: pharmacokinetics, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone pain. J Nucl Med. 1992;33:1451.
Goldenberg DM, Sharkey RM, Paganelli G, et al. Antibody Pretargeting advances cancer radioimmunodetection and radioimmunotherapy. J Clin Oncol. 2006;24:823.
Goldsmith SJ. Radioimmunotherapy of lymphoma: Bexxar and Zevalin. Semin Nucl Med. 2010;40:122.
Hurley JR, Becker DV. Treatment of thyroid cancer with radioiodine (131I). In: Sandler MP, Coleman RE, FJT W, et al., editors. Diagnostic nuclear medicine. 3rd ed. Baltimore: Williams and Wilkins; 1996. p. 959.
Maxon HR III, Smith HD. Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin N Am. 1990;19:685.
Nilsson S, Larsen RH, Foss SD, et al. First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases. Clin Cancer Res. 2005;11:4451.
Package inserts for Theraspheres and SIR-Spheres.
Robinson RG, Preston DF, Schiefelbein M, Baxter KG. Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA. 1995;274:420.
Salem R, Hunter RD. Yittrium-90-micrrospheres for the treatment of hepatocellular carcinoma: a review. Int J Radiat Oncol Biol Phys. 2006;66:583.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Saha, G.B. (2018). Therapeutic Uses of Radiopharmaceuticals in Nuclear Medicine. In: Fundamentals of Nuclear Pharmacy. Springer, Cham. https://doi.org/10.1007/978-3-319-57580-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-57580-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57579-7
Online ISBN: 978-3-319-57580-3
eBook Packages: MedicineMedicine (R0)